{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T11:57:53Z","timestamp":1789732673622,"version":"4.0.1"},"reference-count":18,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunobiology"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.imbio.2018.08.001","type":"journal-article","created":{"date-parts":[[2018,8,6]],"date-time":"2018-08-06T12:23:02Z","timestamp":1533558182000},"page":"772-776","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["High frequency of anti-protein Z antibodies in patients with anticardiolipin antibodies"],"prefix":"10.1016","volume":"223","author":[{"given":"Tojoniaina-Herinjaka","family":"Andriamandimbisoa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Emmanuel","family":"Kahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Bourdain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Fran\u00e7ois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8784-7209","authenticated-orcid":false,"given":"Marc","family":"Vasse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.imbio.2018.08.001_bib0005","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.transci.2017.07.014","article-title":"Anti-phospholipid syndrome: current opinion on mechanisms involved, laboratory characterization and diagnostic aspects","volume":"56","author":"Amiral","year":"2017","journal-title":"Transfus. Apher. Sci."},{"key":"10.1016\/j.imbio.2018.08.001_bib0010","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.semarthrit.2015.05.008","article-title":"The risk of pulmonary embolism and deep venous thrombosis in systemic lupus erythematosus: a general population-based study","volume":"45","author":"Avi\u00f1a-Zubieta","year":"2015","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.imbio.2018.08.001_bib0015","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1055\/s-0037-1616195","article-title":"Protein Z-dependent regulation of coagulation","volume":"86","author":"Broze","year":"2001","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.imbio.2018.08.001_bib0020","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1080\/14767050902801751","article-title":"Maternal anti-protein Z antibodies in pregnancies complicated by pre-eclampsia, SGA and fetal death","volume":"22","author":"Erez","year":"2009","journal-title":"J. Matern. Fetal. Neonatal. Med."},{"key":"10.1016\/j.imbio.2018.08.001_bib0025","doi-asserted-by":"crossref","first-page":"4850","DOI":"10.1182\/blood-2002-12-3802","article-title":"Anti-protein Z antibodies in women with pathologic pregnancies","volume":"101","author":"Gris","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.imbio.2018.08.001_bib0030","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.1073\/pnas.87.11.4120","article-title":"Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H)","volume":"87","author":"McNeil","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.imbio.2018.08.001_bib0035","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.imbio.2018.08.001_bib0040","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1538-7836.2005.01691.x","article-title":"A prospective study of anticardiolipin antibodies as a risk factor for venous thrombosis in a general population (the HUNT study)","volume":"4","author":"Naess","year":"2006","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.imbio.2018.08.001_bib0045","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.thromres.2007.07.009","article-title":"Protein Z levels and anti-protein Z antibodies in patients with arterial and venous thrombosis","volume":"121","author":"Pardos-Gea","year":"2008","journal-title":"Thromb. Res."},{"key":"10.1016\/j.imbio.2018.08.001_bib0050","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1111\/j.1538-7836.2009.03555.x","article-title":"Update of the guidelines for lupus anticoagulant detection. Subcommittee on lupus anticoagulant\/antiphospholipid antibody of the scientific and standardisation committee of the international society on thrombosis and haemostasis","volume":"7","author":"Pengo","year":"2009","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.imbio.2018.08.001_bib0055","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus","volume":"64","author":"Petri","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.imbio.2018.08.001_bib0060","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.autrev.2013.11.004","article-title":"Risk of venous and arterial thrombosis according to type of antiphospholipid antibodies in adults without systemic lupus erythematosus: a systematic review and meta-analysis","volume":"13","author":"Reynaud","year":"2014","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.imbio.2018.08.001_bib0065","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.thromres.2007.09.014","article-title":"Clinical significance of anti-protein Z antibodies in patients with lupus anticoagulant","volume":"122","author":"Sailer","year":"2008","journal-title":"Thromb. Res."},{"key":"10.1016\/j.imbio.2018.08.001_bib0070","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/j.1600-0897.2010.00925.x","article-title":"High Frequency of anti-protein Z IgM and IgG autoantibodies in women with idiopathic recurrent spontaneous miscarriage","volume":"65","author":"Sater","year":"2011","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.imbio.2018.08.001_bib0075","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1160\/TH09-09-0645","article-title":"A meta-analysis of potential risks of low levels of protein Z for diseases related to vascular thrombosis","volume":"103","author":"Sofi","year":"2010","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.imbio.2018.08.001_bib0080","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S0140-6736(00)04218-5","article-title":"Frequency of protein Z deficiency in patients with ischaemic stroke","volume":"357","author":"Vasse","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.imbio.2018.08.001_bib0085","doi-asserted-by":"crossref","first-page":"6734","DOI":"10.1073\/pnas.120081897","article-title":"Prothrombotic phenotype of protein Z deficiency","volume":"97","author":"Yin","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.imbio.2018.08.001_bib0090","doi-asserted-by":"crossref","first-page":"4973","DOI":"10.1182\/blood-2007-12-126391","article-title":"Protein Z-dependent protease inhibitor deficiency produces a more severe murine phenotype than protein Z deficiency","volume":"111","author":"Zhang","year":"2008","journal-title":"Blood"}],"container-title":["Immunobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298518300767?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298518300767?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T16:45:35Z","timestamp":1759250735000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0171298518300767"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":18,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S0171298518300767"],"URL":"https:\/\/doi.org\/10.1016\/j.imbio.2018.08.001","relation":{},"ISSN":["0171-2985"],"issn-type":[{"value":"0171-2985","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High frequency of anti-protein Z antibodies in patients with anticardiolipin antibodies","name":"articletitle","label":"Article Title"},{"value":"Immunobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imbio.2018.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}]}}